Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) and Astrana Health (NASDAQ:ASTH – Get Free Report) are both business services companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.
Valuation and Earnings
This table compares Pharma-Bio Serv and Astrana Health”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Pharma-Bio Serv | $16.98 million | 0.79 | $1.31 million | ($0.03) | -19.37 |
Astrana Health | $1.39 billion | 1.50 | $60.72 million | $1.30 | 28.54 |
Astrana Health has higher revenue and earnings than Pharma-Bio Serv. Pharma-Bio Serv is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Pharma-Bio Serv | 0 | 0 | 0 | 0 | 0.00 |
Astrana Health | 0 | 2 | 6 | 1 | 2.89 |
Astrana Health has a consensus price target of $63.67, indicating a potential upside of 71.61%. Given Astrana Health’s stronger consensus rating and higher probable upside, analysts clearly believe Astrana Health is more favorable than Pharma-Bio Serv.
Institutional and Insider Ownership
52.8% of Astrana Health shares are owned by institutional investors. 12.2% of Pharma-Bio Serv shares are owned by insiders. Comparatively, 8.5% of Astrana Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares Pharma-Bio Serv and Astrana Health’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Pharma-Bio Serv | -7.81% | -5.81% | -4.65% |
Astrana Health | 3.63% | 9.37% | 5.32% |
Volatility and Risk
Pharma-Bio Serv has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Comparatively, Astrana Health has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500.
Summary
Astrana Health beats Pharma-Bio Serv on 14 of the 15 factors compared between the two stocks.
About Pharma-Bio Serv
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.
About Astrana Health
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.